Picture of Seer logo

SEER — Seer News Story

0.000.00%
us flag iconLast trade - 00:00
TechnologyAdventurousSmall CapNeutral

Seer Q4 revenue rises 5% yr/yr, net loss narrows

Overview

Proteomics firm's Q4 revenue rose 5% yr/yr, driven by higher product sales

Net loss for Q4 narrowed to $16 mln from $21.7 mln yr/yr

Operating expenses for Q4 fell 23% due to reduced stock-based compensation

Outlook

Seer expects full-year 2026 revenue between $16 mln and $18 mln

Company faces ongoing budgetary pressures, including NIH funding uncertainty

Seer confident about opportunities in 2026 due to installed base growth

Result Drivers

INSTALLED BASE GROWTH - Seer expanded its installed base to 82 instruments, a 67% increase year-over-year, with 33 instruments installed in 2025

OPERATING EXPENSE REDUCTION - Operating expenses fell 23% in Q4 due to reduced stock-based compensation, laboratory expenses, and professional services

Company press release: ID:nGNX8lQgMF

Key Details

MetricBeat/MissActualConsensus Estimate
Q4 Revenue$4.20 mln
Q4 EPS-$0.29
Q4 Net Income-$15.99 mln
Q4 Gross Margin52%
Q4 Gross Profit$2.18 mln
Q4 Operating Expenses$19.57 mln
Analyst Coverage The one available analyst rating on the shares is "buy" The average consensus recommendation for the office equipment peer group is "buy" For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com. (This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Recent news on Seer

See all news